logo
Coles confirms major price move as Woolworths, Aldi supermarket war heats up: ‘Immediate relief'

Coles confirms major price move as Woolworths, Aldi supermarket war heats up: ‘Immediate relief'

Yahoo2 days ago

Coles is lowering the prices of hundreds of products in-store and online as the competition to win customers over rivals Woolworths and Aldi intensifies. The supermarket giants have been announcing a raft of discounts in the last few weeks.
Coles has revealed plans to cut prices on 307 winter essentials and household staples across meat, bakery, pantry and dairy. It's part of its latest Down Down campaign, which will offer an average saving of 19 per cent for 12 weeks from Wednesday, June 4.
It comes just weeks after Woolworths kicked off the price-slashing competition, lowering the price on 400 items until 2026. Aldi has also thrown its hat into the ring, with CEO Anna McGrath telling Yahoo Finance it 'will not be beaten on the cost of your weekly shop'.
RELATED
Coles and Woolworths checkout move that there's no coming back from: 'Will only accelerate'
Coles, Woolworths shelves reveal devastating reality for coffee lovers: 'From $49 to $62'
Aussie couple making $1,200 a day from job anyone can do: 'Went off like an explosion'
Coles' winter price reductions will be on top of the products currently on Down Down pricing across stores. From Wednesday, customers will be able to shop an average of 588 discounted prices until the end of August.
'This winter we're investing in bringing prices down to deliver immediate relief at the checkout to our customers,' Coles chief commercial officer Anna Croft said.
"Whether it's a leg of lamb roasting in the oven, a freezer full of batch-cooked meals, or a simple stir-fry to feed hungry mouths, Coles is helping households make meals they love at lowered prices.'
Coles has also launched its first Flybuys Activate Bonus Value Points offer, which will give customers 10 times the points on more than 800 items in June. It also has a range of bonus points offered on selected Liquorland products.
Croft said this will allow customers to 'supercharge their points balance' and help them accumulate the 2,000 points needed for $10 off their shop faster.
Woolworths, Australia's biggest supermarket chain, announced it would be lowering prices on nearly 400 popular products until at least 2026 last month.
The supermarket giant claimed families spending $150 on their weekly shop could now save an average of around $15 a week when buying the discounted products, which include chicken schnitzel, greek yoghurt and frozen berries, along with essentials like flour, bread, rice and nappies.
Woolworths CEO Amanda Bardwell said the move marked the start of a 'real, tangible change' for customers and was more than short-term relief.
'This isn't just a short-term promotion; it's about lower shelf prices on the products we know customers regularly shop for, and providing genuine, lasting and dependable value they can count on,' she said.
Aldi has pushed back on offering temporary discounts to customers and claimed it would come on top for customers in the supermarket price war.
"We've been committed to this promise since day one as we understand that trust isn't built on flash sales, and loyalty isn't earned through discounts alone," McGrath told Yahoo Finance.
"So, while some prefer to play a price-drop strategy, we remain focused on what we do best: delivering quality products at everyday low prices. We are committed to maintaining this promise."
Aldi has consistently been found to be the cheapest option by CHOICE's government-funded supermarket price report.
It found Woolworths was $15.83 more expensive than Aldi for a basket of 14 essential items, including milk, butter, bread, pasta, mince and fresh fruit and vegetables.
Coles was $15.33 more expensive, while IGA was $23.54 more.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Chips Ahoy, Oreo maker sues grocery chain over ‘copycat' packaging
Chips Ahoy, Oreo maker sues grocery chain over ‘copycat' packaging

Miami Herald

timean hour ago

  • Miami Herald

Chips Ahoy, Oreo maker sues grocery chain over ‘copycat' packaging

June 3 (UPI) -- The maker of Chips Ahoy cookies is suing a discount grocery store chain, claiming it "blatantly" copied its chocolate chip cookie and other snack packaging to "deceive and confuse" customers. Mondelez, which also makes Oreos and Wheat Thins, filed the federal lawsuit May 27 against German grocer Aldi, seeking monetary damages and a court order to stop Aldi from selling the products. Aldi has more than 2,400 locations in the United States. The suit claims the supermarket chain, which has its U.S. headquarters in Illinois, also copied the snack company's packaging for its Teddy Grahams, Belvita biscuits, Nutter Butters and Ritz crackers. "Defendant is in the business of selling private label cookie and cracker snacks and has a pattern and practice of selling products in packaging that are unacceptable copies of Mondelez's trade dress," the lawsuit states. "Because of this misconduct, Mondelez has a history of enforcing its intellectual property rights against Defendant," the filing continues. "Indeed, Mondelez has contacted Defendant on numerous occasions objecting to Defendant's use of confusingly similar packaging and demanding that Defendant cease and desist its unlawful infringement." In the lawsuit, Mondelez displays side-by-side photos of Chips Ahoy cookies in blue and red packaging and Aldi's Chocolate Chip cookies in a similar blue or red. Nutter Butters in their red packaging are shown next to Aldi's Peanut Butter Creme-filled cookies also in red, and the yellow Wheat Thins box with small square crackers is shown next to Aldi's Thin Wheat crackers box, also in yellow with a picture of small square crackers. "Defendant's actions are likely to deceive and confuse consumers and dilute the distinctive quality of Mondelez's unique product packaging," according to the lawsuit, "and if not stopped, threaten to irreparably harm Mondelez and its valuable brands." Copyright 2025 UPI News Corporation. All Rights Reserved.

Dr. Lily Taheri of The Applecross Dentist Continues to Provide Exceptional Cosmetic Dental Care to Perth Community
Dr. Lily Taheri of The Applecross Dentist Continues to Provide Exceptional Cosmetic Dental Care to Perth Community

Associated Press

time3 hours ago

  • Associated Press

Dr. Lily Taheri of The Applecross Dentist Continues to Provide Exceptional Cosmetic Dental Care to Perth Community

Leading cosmetic dental practice in Applecross delivers comprehensive dental services with advanced technology and personalized patient care. Perth, Western Australia, Australia, June 3, 2025 -- Applecross WA, Australia, June 1, 2025 -- The Applecross Dentist Smile Design Boutique, a premier cosmetic dental practice in Applecross, continues to provide exceptional dental care to the local Perth community. Led by Dr. Lily Taheri, a highly skilled dental professional, The Applecross Dentist has established itself as a trusted provider of comprehensive dental services, combining cutting-edge technology with a patient-centered approach to oral healthcare. As a leading dentist in Applecross, The Applecross Dentist offers an extensive range of dental services, from routine preventive care to advanced cosmetic and restorative procedures. The modern dental facility is equipped with state-of-the-art technology, ensuring optimal treatment outcomes for patients of all ages throughout the Perth metropolitan area. Dr. Taheri brings extensive experience and expertise to the practice, with a commitment to staying at the forefront of dental innovations and techniques. Her dedication to continuing education ensures that patients receive the most current and effective treatments available in modern dentistry. Dr. Taheri is currently the only cosmetic dentist in Western Australia holding the Mastership Certification in Digital Smile Design 'At The Applecross Dentist, we are committed to providing personalized dental care that addresses each patient's individual needs and concerns,' said Dr. Taheri. 'I strongly believe in holistic dentistry, facially driven aesthetics utilizing digital technology and bio-emulative dentistry.' The dental practice offers a full spectrum of services, including general dentistry, cosmetic dentistry, and specialized treatments. Patients can access procedures such as professional teeth cleaning, dental fillings, crowns and bridges, teeth whitening, dental implants, and orthodontic solutions. The practice emphasizes preventive care while also providing advanced cosmetic and restorative options for patients seeking to enhance their smiles. For those seeking an Applecross dental clinic that combines clinical excellence with compassionate care, The Applecross Dentist stands out in the Perth dental community. The practice's comprehensive approach to dental health focuses on building long-term relationships with patients and their families. Patients visiting The Applecross Dentist can expect a professional and comfortable environment. The practice's team is carefully selected for their clinical expertise and commitment to patient care, ensuring that every visit is a positive experience. As a respected dental practice in Perth's southern suburbs, The Applecross Dentist utilizes advanced diagnostic and treatment technologies in both general and cosmetic dentistry. Dr. Taheri's commitment to professional development and continuing education ensures that the practice remains at the forefront of dental care innovations. The practice's comprehensive approach to oral health encompasses preventive care, restorative treatments, and cosmetic enhancements. Whether patients require routine maintenance or complex dental procedures, The Applecross Dentist's team is equipped to provide exceptional care tailored to individual needs. For patients interested in cosmetic dentistry, The Applecross Dentist offers a range of smile enhancement services designed to improve both the appearance and function of teeth. These services are provided with careful attention to achieving natural-looking results that complement each patient's unique features. Dr. Taheri says about the Applecross Dentist Smile Design Boutique, 'The Applecross Dentist has been personally created with love, and equipped with top of the range technology from around the world. Feel free to come in and say hi and together lets create your dream smile.' For more information about The Applecross Dentist and the services provided by Dr. Lily Taheri, please contact the practice directly. About the company: The Applecross Dentist Smile Design Boutique, led by Dr. Lily Taheri, is a premier dental practice located in Applecross, Western Australia. The clinic offers a comprehensive range of general and cosmetic dentistry services, including preventive care, restorative treatments, cosmetic enhancements, and specialized dental procedures for patients throughout the Perth metropolitan area. Contact Info: Name: Dr. Lily Email: Send Email Organization: The Applecross Dentist Smile Design Boutique Address: 4/40 Ardross St, Applecross WA 6153, Australia Phone: +61879489449 Website: Release ID: 89160693 Should you identify any discrepancies, concerns, or inaccuracies in the content provided in this press release or require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team is committed to addressing your concerns within 8 hours by taking necessary actions to resolve identified issues diligently or guiding you through the necessary steps for removal. Our dedication lies in providing accurate and reliable information.

Relacorilant + Nab-Paclitaxel Beneficial in Ovarian Cancer
Relacorilant + Nab-Paclitaxel Beneficial in Ovarian Cancer

Medscape

time4 hours ago

  • Medscape

Relacorilant + Nab-Paclitaxel Beneficial in Ovarian Cancer

Relacorilant, a selective glucocorticoid receptor antagonist, combined with nab-paclitaxel significantly improved progression-free survival in women with platinum-resistant ovarian cancer. The interim analysis also showed meaningful improvement in overall survival, with median survival extending from 11.50 to 15.97 months. METHODOLOGY: While platinum-based chemotherapy is initially effective, about 70% of patients experience disease relapse that becomes platinum-resistant. Relacorilant, a selective glucocorticoid receptor antagonist, has demonstrated synergy with paclitaxel in nonclinical tumor models. The combination with nab-paclitaxel was chosen for this study because it does not require corticosteroid coadministration. Researchers conducted a randomized, controlled, open-label, phase 3 trial (ROSELLA [GOG-3073/ENGOT-ov72]) at 117 hospitals and community oncology treatment centers across 14 countries in Australia, Europe, Latin America, North America, and South Korea. Participants included 381 patients aged 18 years or older with confirmed platinum-resistant epithelial ovarian, primary peritoneal, or fallopian tube cancer; up to three previous lines of anticancer therapy; and measurable disease as per Response Evaluation Criteria in Solid Tumors (version 1.1). Analysis involved comparing relacorilant (150 mg orally the day before, of, and after nab-paclitaxel infusion) plus nab-paclitaxel (80 mg/m2 intravenously on days 1, 8, and 15 of each 28-day cycle) with nab-paclitaxel monotherapy (100 mg/m2 on the same schedule). TAKEAWAY: Patients receiving relacorilant plus nab-paclitaxel showed improved progression-free survival compared with those receiving nab-paclitaxel monotherapy (hazard ratio [HR], 0.70; 95% CI, 0.54-0.91; median, 6.54 months vs 5.52 months; stratified log-rank P = .0076). = .0076). Interim analysis revealed improved overall survival with relacorilant plus nab-paclitaxel vs nab-paclitaxel monotherapy (HR, 0.69; 95% CI, 0.52-0.92; median, 15.97 months vs 11.50 months; log-rank P = .0121). = .0121). Safety profiles were comparable between the groups when adjusted for nab-paclitaxel exposure, with no new safety signals observed. IN PRACTICE: 'Combined with the evidence from previous studies, our study supports relacorilant plus nab-paclitaxel as a potential new standard of care for patients with platinum-resistant ovarian cancer, without the need for biomarker selection. This study is the first positive clinical trial conducted with registrational intent for a selective glucocorticoid receptor antagonist in patients with cancer,' authors of the study wrote. SOURCE: Lead author Alexander B. Olawaiye, MD, of the University of Pittsburgh School of Medicine and UPMC Magee-Womens Hospital, both in Pittsburgh, presented the results of the study at American Society of Clinical Oncology (ASCO) 2025. A paper on the study was published online in The Lancet on June 2. LIMITATIONS: The open-label design and applicability to patients with more than three lines of anticancer therapy were noted as limitations. While the risk of bias in progression-free survival assessment was mitigated by using blinded independent central review and a dual primary endpoint of overall survival, the median duration of the follow-up for overall survival was less than the estimated median overall survival in the relacorilant combination group at interim analysis. DISCLOSURES: The study was funded by Corcept Therapeutics. The authors reported that adverse events were graded according to the National Cancer Institute's Common Terminology Criteria for Adverse Events (version 5.0), with relatedness determined by the investigators. The funding source supported trial conduct, patient enrollment, and drug supply. The analysis, interpretation, writing, and submission decisions were the responsibility of the authors.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store